| MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response M Fabbri, A Paone, F Calore, R Galli, E Gaudio, R Santhanam, F Lovat, ... Proceedings of the National Academy of Sciences 109 (31), E2110-E2116, 2012 | 1742 | 2012 |
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly … R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ... Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009 | 939 | 2009 |
| Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ... Journal of Clinical Oncology 24 (24), 3904-3911, 2006 | 868 | 2006 |
| Transformation of hematopoietic cells by BCR/ABL requires activation of a PI‐3k/Akt‐dependent pathway T Skorski, A Bellacosa, M Nieborowska‐Skorska, M Majewski, R Martinez, ... The EMBO journal, 1997 | 825 | 1997 |
| The biology of CML blast crisis B Calabretta, D Perrotti Blood 103 (11), 4010-4022, 2004 | 735 | 2004 |
| miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ... Cell 140 (5), 652-665, 2010 | 716 | 2010 |
| The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ... Cancer cell 8 (5), 355-368, 2005 | 605 | 2005 |
| RETRACTED: downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development F Pichiorri, SS Suh, A Rocci, L De Luca, C Taccioli, R Santhanam, ... Cancer cell 18 (4), 367-381, 2010 | 543 | 2010 |
| Chronic myeloid leukemia: mechanisms of blastic transformation D Perrotti, C Jamieson, J Goldman, T Skorski The Journal of clinical investigation 120 (7), 2254-2264, 2010 | 528 | 2010 |
| Protein phosphatase 2A: a target for anticancer therapy D Perrotti, P Neviani The lancet oncology 14 (6), e229-e238, 2013 | 495 | 2013 |
| FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia P Neviani, R Santhanam, JJ Oaks, AM Eiring, M Notari, BW Blaser, S Liu, ... The Journal of clinical investigation 117 (9), 2408-2421, 2007 | 437 | 2007 |
| BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2 D Perrotti, V Cesi, R Trotta, C Guerzoni, G Santilli, K Campbell, A Iervolino, ... Nature genetics 30 (1), 48-58, 2002 | 410 | 2002 |
| Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic … S Costinean, SK Sandhu, IM Pedersen, E Tili, R Trotta, D Perrotti, ... Blood, The Journal of the American Society of Hematology 114 (7), 1374-1382, 2009 | 367 | 2009 |
| Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis SA Saddoughi, S Gencer, YK Peterson, KE Ward, A Mukhopadhyay, ... EMBO molecular medicine 5 (1), 105-121, 2013 | 314 | 2013 |
| Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B … G Marcucci, CD Baldus, AS Ruppert, MD Radmacher, K Mrózek, ... Journal of Clinical Oncology 23 (36), 9234-9242, 2005 | 304 | 2005 |
| Sp1/NFκB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia S Liu, LC Wu, J Pang, R Santhanam, S Schwind, YZ Wu, CJ Hickey, J Yu, ... Cancer cell 17 (4), 333-347, 2010 | 301 | 2010 |
| TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and antibody-dependent cellular cytotoxicity in human NK cells R Trotta, JD Col, J Yu, D Ciarlariello, B Thomas, X Zhang, J Allard, M Wei, ... The Journal of Immunology 181 (6), 3784-3792, 2008 | 294 | 2008 |
| BCR/ABL activates mdm2 mRNA translation via the La antigen R Trotta, T Vignudelli, O Candini, RV Intine, L Pecorari, C Guerzoni, ... Cancer cell 3 (2), 145-160, 2003 | 275 | 2003 |
| PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells P Neviani, JG Harb, JJ Oaks, R Santhanam, CJ Walker, JJ Ellis, ... The Journal of clinical investigation 123 (10), 4144-4157, 2013 | 268 | 2013 |
| A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation M Notari, P Neviani, R Santhanam, BW Blaser, JS Chang, A Galietta, ... Blood 107 (6), 2507-2516, 2006 | 241 | 2006 |